Development and Current State of Digital Therapeutics for Irritable Bowel Syndrome

This publication has 58 references indexed in Scilit:

• Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome
  BMC Gastroenterology, 2013
• Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website
  BMC Gastroenterology, 2013
• Psychological Treatments in Functional Gastrointestinal Disorders: A Primer for the Gastroenterologist
  Clinical Gastroenterology and Hepatology, 2013
• Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome
  NeuroImage, 2012
• The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome
  Contemporary Clinical Trials, 2012
• Quality of Life in Patients With Irritable Bowel Syndrome
  Journal of Clinical Gastroenterology, 2011
• Gut-Directed Hypnotherapy:The Manchester Approach for Treatment of Irritable Bowel Syndrome
  International Journal of Clinical and Experimental Hypnosis, 2006
• Standardized Hypnosis Treatment for Irritable Bowel Syndrome:The North Carolina Protocol
  International Journal of Clinical and Experimental Hypnosis, 2006
• Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial
  BMJ, 2005
• Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).
  Gastroenterology, 2003